8 Week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80mg+ Amlodipine 5 mg vs. Amlodipine 5mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 5mg Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 03 Jan 2014
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 04 Oct 2012 Results presented at the 24th Annual Scientific Meeting of the American Society of Hypertension.
- 04 Oct 2012 Primary endpoint 'Diastolic-blood-pressure' has been met.
- 04 Oct 2012 Primary endpoint 'Seated-blood-pressure' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History